The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Background: Migraine has a negative impact on patients’ quality of life, with the frequency of attacks being associated with greater disability and poorer health status. Frequent migraine-type headaches require prophylactic treatment, which has so far been of limited effectiveness until advent of c...
Saved in:
Main Authors: | Monika Remenčiūtė, Greta Varžaitytė, Gintarė Žemgulytė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2024-05-01
|
Series: | Acta Medica Lituanica |
Subjects: | |
Online Access: | https://www.journals.vu.lt/AML/article/view/33184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
by: Hans-Christoph Diener, et al.
Published: (2025-02-01) -
New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01) -
A retrospective analysis of migraine prophylaxis with anti-CGRP monoclonal antibodies at the hospital of Lithuanian University of Health Sciences Kaunas Clinics
by: V. Karpavičiūtė, et al.
Published: (2023-10-01) -
Assessment of the Quality of Life in Patients with Migraine
by: S. Pociūtė, et al.
Published: (2023-12-01) -
Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
by: David Kudrow, et al.
Published: (2024-11-01)